Literature DB >> 31087451

Assessment of Alimentación Normal con Ajuste de Insulina (ANAIS), a Spanish version of the DAFNE programme, in people with Type 1 diabetes: a randomized controlled parallel trial.

R M Sánchez-Hernández1,2, D Alvarado-Martel1,2, Y López-Plasencia1,2, A Carrillo-Domínguez1,2, A Jiménez-Rodríguez1, J Rodríguez-Cordero1, T Vera-Elzo3, Á Santana Del Pino4, F J Nóvoa-Mogollón1,2, A M Wägner1,2.   

Abstract

AIM: To evaluate the effects of Alimentación Normal con Ajuste de Insulina (ANAIS), a group-based, therapeutic education programme for Type 1 diabetes based on a flexible insulin regimen adjusted to the individual's food intake.
METHODS: Participants with Type 1 diabetes and HbA1c levels of 53-86 mmol/mol (7-10%) were recruited from outpatient clinics at a tertiary care centre. They were randomized (using opaque, sealed envelopes, with a 2:1 treatment allocation ratio) to attend the training course immediately (immediate ANAIS; intervention group) or a year later (delayed ANAIS; control group). The main outcome was HbA1c level at 1 year. Secondary outcomes included lipid levels, weight, hypoglycaemic events, insulin dose, treatment satisfaction, self-perceived dietary freedom, quality of life and participant-defined goals.
RESULTS: A total of 48 participants were assigned to the intervention group and 32 to the control group. Twelve months after completing the training, adjusted HbA1c was not significantly different in the intervention group [64 ± 1.3 vs 68 ± 1.6 mmol/mol (8.0 ±0.1% vs 8.4 ±0.1%); P=0.081]. Treatment satisfaction was significantly higher in the intervention group, but no differences were found in hypoglycaemic events, weight, insulin dose or changes in dietary freedom. At 1 year after the intervention, 72% of the participants (vs 33% in the control group; P=0.046) reported exceeding their expectations regarding achievement of their main personal goal.
CONCLUSION: Promoting dietary freedom and empowering people with Type 1 diabetes through structured education programmes, such as ANAIS, improves treatment satisfaction and self-defined goals. No significant improvement in HbA1c level was achieved.
© 2019 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31087451     DOI: 10.1111/dme.13984

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  The Effects of Diabetes Self-Management Education on Quality of Life for Persons With Type 1 Diabetes: A Systematic Review of Randomized Controlled Trials.

Authors:  Patricia Davidson; Jacqueline LaManna; Jean Davis; Maria M Ojeda; Suzanne Hyer; Jane K Dickinson; Andrew Todd; Tamara M Hammons; Shahariar Mohammed Fahim; Cassidi C McDaniel; Cynthia A McKee; Jennifer N Clements; Kirsten Yehl; Michelle L Litchman; Julia E Blanchette; Jan Kavookjian
Journal:  Sci Diabetes Self Manag Care       Date:  2022-01-14

2.  Insulin Requirements and Carbohydrate to Insulin Ratio in Normal Weight, Overweight, and Obese Women With Type 1 Diabetes Under Pump Treatment During Pregnancy: A Lesson From Old Technologies.

Authors:  Camilla Festa; Raffaella Fresa; Natalia Visalli; Olimpia Bitterman; Chiara Giuliani; Concetta Suraci; Marzia Bongiovanni; Angela Napoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

3.  Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial.

Authors:  Sofia Sterner Isaksson; Margareta Bensow Bacos; Björn Eliasson; Eva Thors Adolfsson; Araz Rawshani; Ulf Lindblad; Johan Jendle; Agneta Berglund; Marcus Lind; Mette Axelsen
Journal:  BMJ Open Diabetes Res Care       Date:  2021-03

4.  2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.

Authors:  Kyu Yeon Hur; Min Kyong Moon; Jong Suk Park; Soo-Kyung Kim; Seung-Hwan Lee; Jae-Seung Yun; Jong Ha Baek; Junghyun Noh; Byung-Wan Lee; Tae Jung Oh; Suk Chon; Ye Seul Yang; Jang Won Son; Jong Han Choi; Kee Ho Song; Nam Hoon Kim; Sang Yong Kim; Jin Wha Kim; Sang Youl Rhee; You-Bin Lee; Sang-Man Jin; Jae Hyeon Kim; Chong Hwa Kim; Dae Jung Kim; SungWan Chun; Eun-Jung Rhee; Hyun Min Kim; Hyun Jung Kim; Donghyun Jee; Jae Hyun Kim; Won Seok Choi; Eun-Young Lee; Kun-Ho Yoon; Seung-Hyun Ko
Journal:  Diabetes Metab J       Date:  2021-07-30       Impact factor: 5.376

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.